Skip to main content
NCBI home page
Heart logoLink to Heart
editorial
. 1996 Oct;76(4):293–294. doi: 10.1136/hrt.76.4.293

Beyond cholesterol reduction in coronary heart disease: is vitamin E the answer?

J Cockcroft, P Chowienczyk
PMCID: PMC484535  PMID: 8983670

Full text

PDF
293

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander R. W. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995 Feb;25(2):155–161. doi: 10.1161/01.hyp.25.2.155. [DOI] [PubMed] [Google Scholar]
  2. Anderson T. J., Meredith I. T., Yeung A. C., Frei B., Selwyn A. P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995 Feb 23;332(8):488–493. doi: 10.1056/NEJM199502233320802. [DOI] [PubMed] [Google Scholar]
  3. Berliner J. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995 May 1;91(9):2488–2496. doi: 10.1161/01.cir.91.9.2488. [DOI] [PubMed] [Google Scholar]
  4. Cooke J. P., Tsao P. S. Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb. 1994 May;14(5):653–655. doi: 10.1161/01.atv.14.5.653. [DOI] [PubMed] [Google Scholar]
  5. Gilligan D. M., Sack M. N., Guetta V., Casino P. R., Quyyumi A. A., Rader D. J., Panza J. A., Cannon R. O., 3rd Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol. 1994 Dec;24(7):1611–1617. doi: 10.1016/0735-1097(94)90164-3. [DOI] [PubMed] [Google Scholar]
  6. Hodis H. N., Mack W. J., LaBree L., Cashin-Hemphill L., Sevanian A., Johnson R., Azen S. P. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 1995 Jun 21;273(23):1849–1854. [PubMed] [Google Scholar]
  7. Jacobs M., Plane F., Bruckdorfer K. R. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol. 1990 May;100(1):21–26. doi: 10.1111/j.1476-5381.1990.tb12045.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jukema J. W., Bruschke A. V., van Boven A. J., Reiber J. H., Bal E. T., Zwinderman A. H., Jansen H., Boerma G. J., van Rappard F. M., Lie K. I. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995 May 15;91(10):2528–2540. doi: 10.1161/01.cir.91.10.2528. [DOI] [PubMed] [Google Scholar]
  9. Kritchevsky S. B., Shimakawa T., Tell G. S., Dennis B., Carpenter M., Eckfeldt J. H., Peacher-Ryan H., Heiss G. Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995 Oct 15;92(8):2142–2150. doi: 10.1161/01.cir.92.8.2142. [DOI] [PubMed] [Google Scholar]
  10. Leung W. H., Lau C. P., Wong C. K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993 Jun 12;341(8859):1496–1500. doi: 10.1016/0140-6736(93)90634-s. [DOI] [PubMed] [Google Scholar]
  11. Liao F., Andalibi A., Qiao J. H., Allayee H., Fogelman A. M., Lusis A. J. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994 Aug;94(2):877–884. doi: 10.1172/JCI117409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Matz J., Andersson T. L., Ferns G. A., Anggård E. E. Dietary vitamin E increases the resistance to lipoprotein oxidation and attenuates endothelial dysfunction in the cholesterol-fed rabbit. Atherosclerosis. 1994 Oct;110(2):241–249. doi: 10.1016/s0021-9150(94)90208-9. [DOI] [PubMed] [Google Scholar]
  13. Oliver M. F. Antioxidant nutrients, atherosclerosis, and coronary heart disease. Br Heart J. 1995 Apr;73(4):299–301. doi: 10.1136/hrt.73.4.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rimm E. B., Stampfer M. J., Ascherio A., Giovannucci E., Colditz G. A., Willett W. C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993 May 20;328(20):1450–1456. doi: 10.1056/NEJM199305203282004. [DOI] [PubMed] [Google Scholar]
  15. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  16. Stampfer M. J., Hennekens C. H., Manson J. E., Colditz G. A., Rosner B., Willett W. C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993 May 20;328(20):1444–1449. doi: 10.1056/NEJM199305203282003. [DOI] [PubMed] [Google Scholar]
  17. Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet. 1996 Mar 23;347(9004):781–786. doi: 10.1016/s0140-6736(96)90866-1. [DOI] [PubMed] [Google Scholar]
  18. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991 Dec;88(6):1785–1792. doi: 10.1172/JCI115499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Witztum J. L. The oxidation hypothesis of atherosclerosis. Lancet. 1994 Sep 17;344(8925):793–795. doi: 10.1016/s0140-6736(94)92346-9. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES